Yiqiang Liu

8PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
Distinct Associations of PTEN and TMPRSS4 Expression with Clinical Outcomes and Fudan Immunohistochemistry-Based Subtypes in Triple-Negative Breast Cancer.

|Apr 14, 2025
Efficacy of presurgical therapy with tislelizumab and axitinib to downsize local lesions in locally advanced and metastatic renal cell carcinoma: a single-institution experience with long-term follow-up.

Qiang Zhao, Baoan Hong, Yiqiang Liu

|Mar 23, 2024
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.

Xiaoran Liu, Xiangming Cheng, Feng Xie

|Jan 23, 2024
Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification.

Xiuli Ma, Lixin Zhou, Qi Wu

|Jan 21, 2023
Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer.

Mengping Long, Chong You, Qianqian Song

|Oct 14, 2022
AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status.

Mengping Long, Chong You, Qianqian Song

Pageof 2

Frequent Collaborators

5 joint publications

Taobo Hu

2 joint publications

Shu Wang

2 joint publications

Baosheng Liang

1 joint publications

Liye Mei